Boston Scientific (NYSE: BSX) last traded at $50.37, up 2.03% on the session. The quote above updates while this page is open; the figures below are drawn from Boston Scientific’s own filings and are restated only when a new one is published.
Boston Scientific trades on NYSE under the ticker BSX. It is classified in the Healthcare sector, Medical Devices industry. Its market capitalisation is $73.00 billion.
Healthcare sectorMedical DevicesListed on NYSE
Valuation measures for Boston Scientific, derived from the latest quote and its most recent SEC filing.
| Market cap | $73.00B |
|---|---|
| P/E ratio | 20.39 |
| Price / sales | 3.48 |
| Price / book | 2.93 |
| Beta | 0.19 |
Trailing-twelve-month figures tagged in Boston Scientific's XBRL filings with the SEC.
| Revenue (TTM) | $21.00B |
|---|---|
| Net income (TTM) | $3.67B |
| EPS (TTM) | $2.47 |
| Gross margin | 69.93% |
| Operating margin | 19.78% |
| Return on equity | 14.72% |
| Cash | $539.00M |
Range and volume for BSX over the past 52 weeks.
| 52-week high | $109.50 |
|---|---|
| 52-week low | $42.20 |
| Volume | 35.98M |
| Average volume | 21.17M |
| Previous close | $49.37 |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.